United States - English - NLM (National Library of Medicine)

onpoint, inc. - pyrithione zinc (unii: r953o2rhz5) (pyrithione zinc - unii:r953o2rhz5) - pyrithione zinc 1 g in 100 ml - anti-dandruff helps prevent recurrence of flaking and itching associated with dandruff condition worsens or does not improve after regular use as directed

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - salmonella typhi vi polysaccharide 25ug - solution for injection - 25µg/0.5ml - active: salmonella typhi vi polysaccharide 25ug excipient: dibasic sodium phosphate hydrochloric acid monobasic sodium phosphate dihydrate phenol sodium chloride sodium hydroxide water for injection - typhim vi™ is indicated for active immunisation against typhoid fever caused by salmonella typhi in individuals 2 years of age and over.

Malta - English - Medicines Authority

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - vi polysaccharide, of salmonella, typhi - solution for injection - vi polysaccharide of salmonella typhi 25 µg - vaccines

United States - English - NLM (National Library of Medicine)

sanofi pasteur inc. - salmonella typhi ty2 vi polysaccharide antigen (unii: 7194h8w3kt) (salmonella typhi ty2 vi polysaccharide antigen - unii:7194h8w3kt) - salmonella typhi ty2 vi polysaccharide antigen 25 ug in 0.5 ml - typhim vi vaccine is indicated for active immunization for the prevention of typhoid fever caused by s typhi and is approved for use in persons two years of age or older. immunization with typhim vi vaccine should occur at least two weeks prior to expected exposure to s typhi . typhim vi vaccine is not indicated for routine immunization of individuals in the united states (us). (14) selective immunization against typhoid fever is recommended under the following circumstances: 1) travelers to areas where a recognized risk of exposure to typhoid exists, particularly ones who will have prolonged exposure to potentially contaminated food and water, 2) persons with intimate exposure (ie, continued household contact) to a documented typhoid carrier, and 3) workers in microbiology laboratories who frequently work with s typhi . (14) typhoid vaccination is not required for international travel, but is recommended for travelers to such areas as africa, asia, and central and south america where there is a recognized r

United States - English - NLM (National Library of Medicine)

vi-jon, llc - pramoxine hcl 1%, zinc acetate 0.1% - external analgesic skin protectant - for the temporary relief of pain and itching associated with minor skin irritations and rashes due to poison ivy, poison oak or poison sumac - dries the oozing and weeping of poison:  - ivy - oak - sumac - condition worsens - symptoms last more than 7 days or clear up and occur again within a few days

United States - English - NLM (National Library of Medicine)

vi-jon, llc - diphenhydramine hcl 2%, zinc acetate 0.1% - external analgesic skin protectant - for the temporary relief of pain and itching associated with ■ insect bites ■ minor skin irritations ■ sunburn ■ minor burns ■ minor cuts ■ scrapes ■ rashes due to poison: ■ ivy ■ oak ■ sumac - dries the oozing and weeping of poison: ■ ivy ■ oak ■ sumac - on large areas of the body - with any other product containing diphenhydramine, even one taken by mouth ■ on chicken pox ■ on measles ■ condition worsens ■ symptoms last more than 7 days or clear up and occur again within a few days

United States - English - NLM (National Library of Medicine)

vi-jon - menthol 0.15%, zinc oxide 1.0% - external analgesic skin protectant uses for the temporary relief of paina and itching due to: - monor cuts - sunburn - insect bites - poison ivy - poison oak - poison sumac - scrapes - minor burns - minor skin irritations dries the oozing and weeping of: - poison ivy - poison oak - poison sumac condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - salmonella typhi vi polysaccharide, quantity: 0.025 mg - injection, solution - excipient ingredients: monobasic sodium phosphate; phenol; water for injections; sodium chloride; dibasic sodium phosphate dihydrate - for the active immunisation against typhoid fever, in subjects over 5 years of age. indications as at 9 october 2000: typhim vi is indicated for active immunisation against typhoid fever in subjects 2 years of age and over.

United States - English - NLM (National Library of Medicine)

vi-jon, llc - pyrithione zinc (unii: r953o2rhz5) (pyrithione zinc - unii:r953o2rhz5) - antidandruff helps prevent recurrence of flaking and itching associated with dandruff - condition worsens or does not improve after regular use as directed

United States - English - NLM (National Library of Medicine)

vi-jon, llc - pyrithione zinc (unii: r953o2rhz5) (pyrithione zinc - unii:r953o2rhz5) - anti-dandruff helps prevent recurrence of flaking and itching associated with dandruff - condition worsens or does not improve after regular use as directed